37 Quantitative Approaches to Disease Mechanisms and Therapies I


Description:
This session highlights applying conventional – e.g., reaction and transport phenomena – and emerging – e.g., dynamical systems and statistical mechanics – concepts from (bio)chemical engineering to aid in understanding disease mechanisms and designing therapies. Submissions that integrate experimental work with simulation and that demonstrate a clear connection between engineering fundamentals and disease pathophysiology are particularly encouraged.

Sponsor:
Engineering Fundamentals in Life Science


Chair:
Stacey D. Finley
Assistant Professor
University of Southern California
Biomedical Engineering
Los Angeles, CA
90089
Email: sfinley@usc.edu

Co-Chair:
Belinda S. Akpa
Assistant Professor
North Carolina State University
Molecular Biomedical Sciences
810 S Clinton Street
Raleigh, NC
60607
Fax Number: 312-996-0808
Email: bsakpa@ncsu.edu


Papers:
37a
Towards the Optimal Design of a Minimal Set of Clinical Tests for the Identification and Characterization of Von Willebrand Disease
Beatrice Taverna, University College London; Alessandra Casonato, University of Padova Medical School; Fabrizio Bezzo, University of Padova; Federico Galvanin, University College London
37b
Experimental Verification of Endothelial Cell Aquaporin-1 Expression's Influence on Sub-Endothelial Intima Thickness and Relevance to Early Atherosclerosis
Roman Yakobov, Energy Institute, City College of New York; Klaudio Mitri, City College of New York; Deyvi Tenemaza, City College of New York; Kung-Ming Jan, College of Physician and Surgeons, Columbia University; David Rumschitzki, Department of Chemical Engineering, City College of City University of New York
37c
Mathematical Modeling and Data Analytics Using WBC Populations for the Prognosis and Diagnosis of Acute Coronary Syndrome
Anwesha Chaudhury, Harvard Medical School; John Higgins, Massachusetts General Hospital
37d
Impact of Red Blood Cell Rigidity on the Vascular Wall Adhesion of Neutrophils: Implication in the Pathology of Sickle Cell Disease
Mario Gutierrez, University of Michigan; Margaret Fish, University of Michigan; Omolola Eniola Adefeso, University of Michigan
37e
Model-Based Novel Strategy for Individualized Treatment of Sickle Cell Disease with Hydroxyurea
Akancha Pandey, Purdue University; Robert Hannemann, Purdue University; Monica Khurana, Indiana University; Seethal Jacob, Indiana University; Terry Vik, Indiana University; Sangtae Kim, Purdue University; Doraiswami Ramkrishna, Purdue University
37f
M2-Mediated Influenza Virus Budding and Scission: From Basic Principles to Control
Jesper J. Madsen, The University of Chicago; John M. A. Grime, The University of Chicago; Gregory A. Voth, The University of Chicago
37g
Transport of Molecular Motors on Networks of Cytoskeletal Filaments
Paul J. Mlynarczyk, University of Tennessee; Steven M. Abel, University of Tennessee
37h
Pathway Analysis of Combined in Utero exposure to Heavy Metals and Phthalates and Its Association with Child Psychomotor Development
Dimosthenis Sarigiannis, Aristotle University of Thessaloniki; Nafsika Papaioannou, Aristotle University of Thessaloniki; Aikaterini Gabriel, Aristotle University of Thessaloniki; Kinga Polanska, Nofer Institute for Occupational Medicine; Evangelos Handakas, Aristotle University of Thessaloniki; Spyros Karakitsios, Aristotle University of Thessaloniki
Abstract Submissions Closed
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division
<< Previous Session | Next Session >>